Has Gordon Grado, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,007 in general payments to Gordon Grado, MD across 197 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gordon Grado, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gordon Grado, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gordon Grado, MD

Radiation Oncology · Scottsdale, AZNPI 1225092745

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Novocure Inc. at 32.2% of the total. Reporting peaked in 2024 at $5,193 and has fallen 83.3% since, to $867 in 2025. Among radiation oncology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,007in general payments, 2019–2025

Across 197 payments — averaging $60.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novocure Inc.$4K
Reflexion Medical, Inc.$2K
Isoray, Inc$1K
Blue Earth Diagnostics$839
Boston Scientific$426
Medtronic$318
plus $3K from 39 others

What the payments were for

Speaking & faculty fees$3,60030%
Travel & lodging$2,54321%
Food & beverage$5,66047%
Education$2042%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novocure Inc.	9	$3,860
Reflexion Medical, Inc.	10	$2,355
Isoray, Inc	10	$1,265
Blue Earth Diagnostics	39	$839
Boston Scientific	5	$426
Medtronic	4	$318
Progenics Pharmaceuticals, Inc.	10	$308
Novartis	12	$249
Johnson & Johnson	13	$245
Lilly USA, LLC	5	$231
Accuray Incorporated	5	$185
Elekta, Inc.	3	$164
Merck	9	$157
Tersera Therapeutics LLC	6	$147
Intuitive Surgical	1	$131
Bayer	7	$126
AstraZeneca(2 entities)	5	$87
Tactile Systems Technology Inc	3	$85
Verity Pharmaceuticals Inc.	4	$78
Amgen	4	$70
Sanofi	3	$65
Accord Healthcare, Inc.	3	$61
MIM Software Inc.	1	$60
Myovant Sciences Inc.	2	$50
Tempus AI, Inc	2	$44
Karyopharm Therapeutics Inc.	1	$32
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Kyowa Kirin, Inc.	2	$30
Dendreon Pharmaceuticals LLC	1	$27
Sun Pharmaceutical Industries Inc.	1	$23
Boehringer Ingelheim	1	$22
Laborie Medical Technologies Corp.	1	$21
Pfizer	1	$21
Incyte Corporation	1	$19
EMD Serono, Inc.	1	$19
Regeneron Healthcare Solutions, Inc.	1	$18
Immunitybio, Inc.	1	$18
Beone Medicines USA, Inc.	1	$18
AVEO Pharmaceuticals, Inc.	1	$18
Mimedx Group, Inc.	1	$16
AbbVie	1	$16
Apellis Pharmaceuticals, Inc.	1	$16
Myriad Genetic Laboratories, Inc.	1	$14
Sumitomo Pharma America, Inc.	1	$13
Heron Therapeutics, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REFLEXION MEDICAL RADIOTHERAPY SYSTEM$2,332
Brachytherapy Source$1,065
SPACEOAR$296
Da Vinci Surgical System$131
OSTEOCOOL RF ABLATION$131
PYLARIFY$123
KYPHON Balloon Kyphoplasty$100

How this compares

$12,007 in reported general payments places this provider in the 90th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$1,136,694

Medicare patients

372

Services billed

5,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	328	$6,373
Bicalutamide	27	$1,409
Silodosin	11	$676
Ciprofloxacin Hcl	45	$372
Doxazosin Mesylate	24	$341
Tramadol Hcl	55	$220
Levofloxacin	35	$120
Acyclovir	11	$106
Azithromycin	11	$27

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Scottsdale

Carlos VargasScottsdale$22K
Vershalee ShuklaScottsdale$19K
Aaron AmbradScottsdale$18K
Terence SioScottsdale$15K
Gregory MaggassScottsdale$11K
Scott TannehillScottsdale$8K
Randa TaoScottsdale$6K
Apar GuptaScottsdale$6K
Chi ZhangScottsdale$4K
Ammoren DohmScottsdale$4K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →